Elsevier

Vaccine

Volume 33, Issue 43, 26 October 2015, Pages 5822-5828
Vaccine

What determines uptake of pertussis vaccine in pregnancy? A cross sectional survey in an ethnically diverse population of pregnant women in London

https://doi.org/10.1016/j.vaccine.2015.08.093Get rights and content

Highlights

  • Uptake of pertussis vaccine in pregnancy in our population was only 26%.

  • Although nationally recommended, only 63% of pregnant women interviewed were even aware of the pertussis vaccination programme.

  • Lack of encouragement from healthcare professionals was identified as the main reason.

  • 91% of women believed healthcare professionals need to become more engaged in providing timely information about vaccines in pregnancy.

Abstract

Introduction

Following the major outbreak of pertussis and 14 infant deaths across England in 2012, the Department of Health (DH) introduced the UK's first maternal pertussis vaccination programme. Data published by Public Health England (PHE) suggest uptake of the vaccine varies considerably across the country. The reasons for this heterogeneity need to be addressed to optimise the impact of the programme.

Objective

To assess uptake of antenatal pertussis and influenza vaccine in a leading NHS Trust in London and to explore awareness and attitudes of pregnant women towards the pertussis vaccination programme.

Design

A cross sectional survey was conducted in an ethnically diverse group of 200 pregnant women accessing antenatal care at Imperial Healthcare NHS Trust. Quantitative data was tabulated and content analysis was carried out on the free text. Qualitative data was divided into themes for accepting or declining the vaccine.

Results

Awareness of the programme was 63% (126/200) with actual uptake of the vaccine only 26.0% (52/200). Women had received information from multiple sources, primarily General Practitioners (GP) and midwives. 34.0% (68/200) of women were offered the vaccine at their GP practice, only 24% reported a meaningful discussion with their GP about it. Uptake differed by up to 15.0% between ethnicities. Qualitative data showed that uptake could be significantly enhanced if vaccination was recommended by a familiar healthcare professional. Feeling uninformed, lack of professional encouragement and uncertainties of risk and benefit of the vaccine were the greatest barriers to uptake.

Conclusion

Vaccine uptake in this cohort of pregnant women was poor. Understanding the target audience and engaging with key groups who influence women's decision-making is essential. Knowledgeable health care professionals need to recommend the vaccine and provide accurate and timely information to increase success of this important programme.

Introduction

Pertussis (whooping cough) is a highly contagious, acute bacterial infection of the respiratory tract caused by Bordetella pertussis. This exclusively human pathogen can affect people of all ages. Whilst adolescents and adults often display relatively mild symptoms, in unimmunised newborn infants the disease may run a severe course resulting in a high rate of complications and death [1], [2]. Pertussis persists as an infection of significant global public health importance leading to 126,000 deaths worldwide in children up to the age of 5 years in 2013 [3].

Fortunately, wide-scale childhood vaccination programmes have been influential in reducing the morbidity and mortality associated with pertussis [4], [5], [6], [7]. However, despite high vaccine coverage, a sharp increase in cases has been observed over the past decade [8], [9], [10], [11] in several countries in Europe, North America and Australia, most likely due to waning immunity after the introduction of the acellular pertussis vaccine [12]. In the UK, pertussis currently remains the most common cause of hospitalisation and deaths in infants from a vaccine-preventable disease [5], [13].

In late 2011 the UK witnessed a remarkable resurgence of confirmed pertussis cases to a level not seen for almost 20 years. By 2012, infected cases had risen tenfold and the outbreak was extending to infants too young to be protected through routine vaccination. Sadly, a total of 14 infant deaths were reported in England in that year. Consequently, an urgent review by the UK Joint Committee on Vaccination and Immunisation (JCVI) recommended to the Department of Health (DH) that pregnant women should be offered routine vaccination with a five component acellular-pertussis-containing vaccine, and this programme was initiated in October 2012, and was offered to all pregnant women between 28 and 38 weeks of pregnancy within the UK National Health Service (NHS) [14].

A subsequent Public Health communications campaign to inform women about the need for vaccination and to stimulate uptake ran for approximately 5 months, including publication of a range of printed materials, available on order. Communication with healthcare professionals used DH and NHS channels and relied upon Heads of Profession to convey key messages and clinical information about pertussis. The Primary Care Trusts (PCTs) were asked to establish vaccination services quickly using local GP Practices [15]. Vaccine stocks were delivered to GP practices and the hospital pharmacy held only a limited stock of vaccine for women who were long-term antenatal inpatients.

The intervention aims to minimise morbidity and prevent further infant deaths by boosting pre-existing maternal immunity and protect newborns indirectly via transplacentally transferred protective antibody, prior to receiving their own vaccines within the infant immunisation schedule. During the summer of 2014 the upper gestation recommended for receiving the vaccine was reduced to 32 weeks, in light of recent evidence [16] to ensure sufficient antibody transfer from mother to baby prior to birth.

Despite measures taken to promote pertussis vaccination, monthly figures published by Public Health England (PHE) since the start of the campaign have revealed varied vaccine uptake across England with London achieving 53.3% coverage at best in February 2013 [17].

In 2013 and 2014, a further 10 deaths in infants occurred with nine of these infants born to non-vaccinated mothers. In light of these data and the recent announcement that the vaccination programme will continue for a further five years [18], evaluation of the current pertussis vaccination programme in pregnancy is, therefore, timely and essential to inform the long-term strategy for optimising pertussis control.

We undertook a cross sectional survey to evaluate women's awareness, attitudes towards and acceptance of the current pertussis vaccination programme in order to identify potential barriers that could be addressed in order to improve implementation.

Section snippets

Study design

This study adopted qualitative and quantitative research techniques in the form of a cross-sectional questionnaire survey. Self-reported qualitative information on attitudes to vaccines and experiences was gained from the analysis of the free text.

Ethical considerations

Ethical approval was granted by the London-Hampstead Research Ethics Committee reference:13/LO/1712.

Theoretical framework and questionnaire development

A four part, anonymised questionnaire was developed based upon the Precaution Adoption Process Model and the Health Belief Model of health behaviour

Results

205 questionnaires were distributed to eligible women. Five questionnaires were excluded due to insufficient response to multiple questions. 200 were completed and analysed (97.0% response rate).

Discussion

Despite an ongoing public health campaign to promote pertussis vaccination during pregnancy in the UK and new cases in infants in the community, uptake has varied considerably across the country and has remained comparatively low in London.

We assessed the awareness and attitudes to pertussis vaccination in pregnancy using both quantitative and qualitative tools. Only 26.0% of women in our cohort had received the vaccine, considerably less than the 62.3% national coverage recently reported by

Author's contributions

The study was conceived by BK, BD and LR. The questionnaires were developed and implemented by BD and PJ with critical input from BH, LR and BK. The database was designed by BK and BL. The data entry and analysis of results was conducted by BD, PJ and BK. The first draft of the manuscript was developed by BD and BK and subsequent versions had input from all authors. The final submission has been approved by all authors. We affirm that the manuscript is an honest, accurate, and transparent

Competing interest statement

All authors declare that no support from any organisation for the submitted work has been received. There is no financial relationships with any organisations that might have an interest in the submitted work, and no other relationships or activities that could appear to have influenced the submitted work.

Funding

This study was funded by a grant from the Imperial College Biomedical Research Centre to BK. BK is also supported by a programme grant from the MRC (MC_UP_A900/1122). The research was conducted independently from its funders.

Acknowledgements

We acknowledge the Midwives and Obstetricians in the antenatal clinics who facilitated recruitment and thank all of the pregnant women who filled in the questionnaires.

References (44)

  • J.A. Sim et al.

    ‘Out of two bad choices I took the slightly better one’: vaccination dilemmas for Scottish and Polish migrant women during the H1N1 influenza pandemic

    Public Health

    (2011)
  • E.O. Kharbanda et al.

    Exploring pregnant women's views on influenza vaccination and educational text messages

    Prev Med

    (2011)
  • Health Protection Scotland. Increased levels of pertussis circulating in Scotland. eWeekly Report 25 April 2012....
  • Public Health England. Whooping cough (pertussis)....
  • S.W. Roush et al.

    Historical comparisons of morbidity and mortality for vaccine-preventable disease in the united states

    JAMA

    (2007)
  • H. Campbell et al.

    Accelerating the control of pertussis in England and Wales

    Emerg Infect Dis

    (2012)
  • Minutes of the meeting held on Monday 9 October 2000

    (2000)
  • D. Güri et al.

    Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990–1996

    Clin Infect Dis

    (1999)
  • W.K. Yih et al.

    The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989–1998

    J Infect Dis

    (2000)
  • L.P. Celetano et al.

    Resurgence of pertussis in Europe

    Pediatr Infect Dis J

    (2005)
  • H.E. Quinn et al.

    Pertussis epidemiology in Australia over the decade 1995–2005 – trends by region and age group

    Commun Dis Intell

    (2007)
  • R. Koepke et al.

    Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand

    J Infect Dis

    (2014)
  • Cited by (0)

    View full text